EUVIMEDEUVIMED entdecken
Fallbericht

ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report

Christopher Rossmann, Michael Stotz, Jasminka Igrec iD, Bernadette Liegl-Atzwanger, Joanna Szkandera, Georg Richtig iD

JCO Precision Oncology · 2026-06 · 10 (6)

DOI: 10.1200/po-25-01189 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCO Precision Oncology, 2026-06. Verfasst von Christopher Rossmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Division of General Radiological Diagnostics, Department of Radiology, Medical University of Graz, Graz, Austria.
  • Diagnostic and Research Institute of Pathology, Medical University Graz, Graz, Austria.

ORCID-Profile: Jasminka Igrec, Georg Richtig

Zitieren

APA

Rossmann, C., Stotz, M., Igrec, J., Liegl-Atzwanger, B., Szkandera, J., & Richtig, G. (2026). ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report. JCO Precision Oncology, 10(6). https://doi.org/10.1200/po-25-01189

Vancouver

Rossmann C, Stotz M, Igrec J, Liegl-Atzwanger B, Szkandera J, Richtig G. ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report. JCO Precision Oncology. 2026;10(6). doi:10.1200/po-25-01189

BibTeX
@article{Rossmann2026,
  author = {Rossmann, Christopher and Stotz, Michael and Igrec, Jasminka and Liegl-Atzwanger, Bernadette and Szkandera, Joanna and Richtig, Georg},
  title = {ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report},
  journal = {JCO Precision Oncology},
  year = {2026},
  volume = {10},
  number = {6},
  doi = {10.1200/po-25-01189}
}
Kostenlos starten →